BioWorld MedTech

Feb. 6, 2017

View Archived Issues

Elekta secures FDA clearance for Venezia cervical cancer treatment device

Elekta AB has received FDA clearance for its Venezia applicator for gynecological brachytherapy. The device is positioned to treat advanced-stage cervical cancer and has had a CE mark since last year. Read More

Wearable micropump from Cambridge cluster disrupts device design

Read More

Questions about device class persist regarding accessory guidance final

Read More

Seroba raises $108M in first close of third fund

Read More

Appointments and advancements

Read More

Financings

Read More

Product briefs

Read More

MDD's Stock Report

Read More

Other news to note

Read More

MDD's Neurology Extra

Read More